Ludmila Smolyansky Sells Shares of Lifeway Foods

Ludmila Smolyansky sold 45,616 shares of Lifeway Foods for $1.35 million.

Key Points

  • Ludmila Smolyansky sold 45,616 shares of Lifeway Foods, Inc. on June 25, 2026, at $29.65 per share, totaling about $1.35 million.
  • Lifeway Foods, trading on NasdaqGM under LWAY, has a market cap of $449.1 million and a P/E ratio of 30.6.
  • Analysts have a buy consensus on Lifeway Foods, with a mean price target of $34.5.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Ludmila Smolyansky sold 45,616 shares of Lifeway Foods, Inc. (NasdaqGM: LWAY) on June 25, 2026. The shares were sold at an average price of $29.65 each, bringing the total transaction value to approximately $1.35 million. This sale was not part of a pre-arranged trading plan.

Insider Buying and Selling at Lifeway Foods, Inc.

Several insiders have been active in trading Lifeway Foods' shares recently. Ludmila Smolyansky sold 40,000 shares on June 24, 2026, at $30.12 each. Edward Smolyansky also sold shares on June 24 and June 22, totaling 88,452 shares at prices ranging from $26.20 to $29.85. Additionally, Julie Smolyansky, the company's CEO, sold 4,251 shares at $25.00 on June 17, 2026, and another 10,293 shares on the same day at an undisclosed price.

Lifeway Foods, Inc. Stock Up 11.5%

As of Saturday, shares of Lifeway Foods traded near $29.39. The company has a market capitalization of approximately $449.1 million. It sports a price-to-earnings (P/E) ratio of 30.6 and a forward P/E ratio of 21.5. The stock has shown a 52-week range between $17.31 and $34.20. Its 50-day moving average is $25.65, while the 200-day moving average stands at $24.12. Lifeway Foods has a relatively low beta of 0.485, indicating less volatility compared to the market.

Year to date

$LWAY stock price

Daily closing prices, year to date. Not investment advice.

Analysts Set New Price Targets

On April 28, 2026, Freedom Broker initiated coverage on Lifeway Foods with a buy rating and set a price target of $34.00. Benchmark also initiated a buy rating with a $35.00 target on November 13, 2025. The consensus among analysts is a buy, with a mean target price of $34.5 from two analyst opinions.

About Lifeway Foods

Lifeway Foods, Inc., headquartered in Morton Grove, Illinois, produces and markets probiotic-based products across North America. Its main product is drinkable kefir, a cultured dairy product offered in various sizes and flavors. The company also produces European-style soft cheeses, drinkable yogurt, and ProBugs, a line of kefir products for kids. Lifeway Foods distributes its products under various brand names, including Lifeway and GlenOaks Farms, through direct sales and brokers.

Bottom Line

Ludmila Smolyansky's recent sale of Lifeway Foods shares adds to a series of insider transactions. Investors often watch such activity for potential insights into company performance. Lifeway Foods continues to attract attention with its probiotic products and analyst buy ratings. As always, it's important to remember that insider transactions are disclosed after the fact and do not necessarily indicate future stock performance.

Get Lifeway Foods, Inc. alerts

New 13F filings, insider trades, and analyst moves on $LWAY, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.